Keyphrases
Human Mesenchymal Stem Cells (hMSCs)
100%
Mesenchymal Stromal Cells
100%
Ischemic Heart Failure
100%
Cell Treatment
100%
Hospitalization
50%
Intramyocardial Injection
50%
Placebo Groups
33%
Between-group
33%
Left Ventricular Ejection Fraction
33%
Left Ventricular End-diastolic Volume (LVEDV)
33%
Myocardial Mass
33%
Bone Marrow Mononuclear Cells
33%
Confidence Interval
16%
Placebo
16%
Randomized Placebo-controlled Trial
16%
AIMS™
16%
Computed Tomography
16%
Dose Effect
16%
Magnetic Resonance Imaging
16%
Treatment Options
16%
Further Treatment
16%
Stroke Volume
16%
Angina
16%
Quality of Life Assessment
16%
Myocardial Function
16%
New York Heart Association Class
16%
Scar Tissue
16%
Imaging Tomography
16%
Scar Quality
16%
Medicine and Dentistry
Heart Failure
100%
Mesenchymal Stem Cell
100%
Heart Muscle Ischemia
100%
Placebo
44%
Heart Left Ventricle Ejection Fraction
22%
End-Systolic Volume
22%
Side Effect
11%
Quality of Life
11%
Angina pectoris
11%
Computer Assisted Tomography
11%
Dose Response
11%
Magnetic Resonance Imaging
11%
Heart Function
11%
Stroke Volume
11%
New York Heart Association Class
11%
Scar Tissue
11%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Heart Failure
100%
Heart Muscle Ischemia
100%
Side Effect
25%